Urology Doctors in Salt Lake City, UT Accepting Medicare

40 Urology doctors found. Showing 21 - 40

Andrew William Southwick, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-7674

Dr. Christopher Burr Dechet, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1950 Circle Of Hope Dr, Rm 6755, Salt Lake City, UT 84112 Phone: 801-587-4383    Fax: 801-585-0151

Dr. Michael C. Wallis, M.D. Urology - Pediatric Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-5555

Steven C Lynch, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 324 10th Ave, Ste 100, Salt Lake City, UT 84103 Phone: 801-408-3771    Fax: 801-408-3772

Laurel S. Mast, MD Urology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 3b427, Salt Lake City, UT 84132 Phone: 801-213-2700

Bradley J. Waterman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1060 E 100 S, Suite 110, Salt Lake City, UT 84102 Phone: 801-531-9453    Fax: 801-531-9467

James R Craig Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4252 S Highland Dr Ste 200, Salt Lake City, UT 84124 Phone: 801-993-1800    Fax: 801-993-1699

Jordan A. Powell, MD Urology Medicare: Medicare Enrolled Practice Location: 30 N. Mario Capecchi Drive Rm 4s100, Salt Lake City, UT 84112 Phone: 801-581-2121

Mikolaj J. Filon, MD Urology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 3b427, Salt Lake City, UT 84132 Phone: 801-213-2718

Sara Marie Lenherr, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E Rm 3b420, Salt Lake City, UT 84132 Phone: 801-213-2700

Sharon P. Lo, MD Urology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121

Dr. Richard V. Matern, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 324 10th Ave, Ste 100, Salt Lake City, UT 84103 Phone: 801-408-3771    Fax: 801-408-3772

Dr. Ned Legrande Mangelson, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 2691 Roxbury Cir, Salt Lake City, UT 84108 Phone: 801-582-4567

Matthew S. Swallow, MD Urology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 3b427, Salt Lake City, UT 84132 Phone: 801-213-2700

Blake D. Hamilton, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-587-4888

Lindsey N. Wright, MD Urology Medicare: Medicare Enrolled Practice Location: 30 N Mario Capecchi Dr Rm 4s100, Salt Lake City, UT 84112 Phone: 801-581-2121

Dr. Robert A Stephenson, M.D. Urology - Pediatric Urology Medicare: Accepting Medicare Assignments Practice Location: 1950 Circle Of Hope Dr, Salt Lake City, UT 84112 Phone: 801-587-4385    Fax: 801-585-3749

Martin Yukpoon Tam, MD Urology Medicare: Medicare Enrolled Practice Location: 1002 E South Temple, Salt Lake City, UT 84102 Phone: 801-521-2102    Fax: 801-521-2830

Dr. Stanford S. Putman, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 324 10th Ave Ste 178, Salt Lake City, UT 84103 Phone: 801-408-2500    Fax: 801-408-1410

Glen Alexander Lau, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E, #1c412, Salt Lake City, UT 84132 Phone: 901-232-1073

News Archive

TADA holds panel discussion to address domestic violence

TADA (Teens Against Domestic Abuse), the first organization of its kind created and led by South Florida teens, will hold a panel discussion on November 5th, 2009. Presented by Sapere Group, the event, "Break the Silence: Break the Cycle," is aimed to shed light on domestic violence and how it transcends age, social and ethnic groups.

Exelixis files investigational new drug application for anticancer compound

Exelixis, Inc. announced today that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for XL888, a novel anticancer compound. XL888 is an orally available small molecule inhibitor of HSP90, which is a chaperone protein that promotes the activity and stability of a range of key regulatory proteins, including kinases.

Enzalutamide Phase 2 study for AR positive triple-negative breast cancer meets primary endpoint

Astellas Pharma Inc. announced that data from a Phase 2 study evaluating the investigational use of enzalutamide as a single agent for the treatment of advanced androgen receptor (AR) positive, triple-negative breast cancer (TNBC) were presented during an oral abstracts session at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Nanoviricide drug candidate effectiveness confirmed against rabies and influenzas

NanoViricides, Inc. has said that in a confirmatory study, their nanoviricide drug candidates exhibited a consistent 20% to 30% survival in the test animals.

Read more Medical News

› Verified 2 days ago

• 1
• 2(current)